BIOSYM A/S: Financial statements 2025
CVR: 21774189
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BIOSYM A/S (CVR 21774189) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. That is an increase of 45.4% compared with the year before. Equity in the 2025 report amounted to DKK 46,311,564. The solvency ratio was 63.8%. The company had 19 employees in the financial year.
- Gross Profit
- DKK 23,552,721
- Profit/Loss
- DKK 8,530,373
- Equity
- DKK 46,311,564
- Total Assets
- DKK 72,549,949
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 23.6 mio. | 8.5 mio. | 46.3 mio. | 19 |
| 2024 | - | 16.2 mio. | 3.8 mio. | 37.8 mio. | 19 |
| 2023 | - | 15.3 mio. | 4.1 mio. | 34 mio. | 18 |
| 2022 | - | 13 mio. | 2.1 mio. | 29.9 mio. | 18 |
| 2021 | - | 18.6 mio. | 7.1 mio. | 27.7 mio. | 18 |
Official annual report
How creditworthy is BIOSYM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BIOSYM A/S has published its annual report for 2024. Gross profit came to DKK 16,196,407, and the net result was DKK 3,810,817.
As of March 27, 2025, Elina Liisa Maarit Haavisto has joined the board of directors of BIOSYM A/S.
As of March 27, 2025, Sebastian Nordman has left the board of directors of BIOSYM A/S.
About BIOSYM A/S
BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.